Predict your next investment

HEALTHCARE | Drug Development
elcelyx.com

See what CB Insights has to offer

Total Raised

$90.34M

Investors Count

6

Deal Terms

6

Elcelyx Therapeutics Funding, Elcelyx Therapeutics Valuation & Elcelyx Therapeutics Revenue

8 Fundings

Elcelyx Therapeutics's latest funding round was a Debt for $0.48M on November 7, 2018.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/7/2018

Debt

$0.48M

Undisclosed Investors

1

10/1/2015

Series E

$99M

10

2/19/2015

Series D - II

$99M

10

2/21/2014

Series D

$99M

10

2/14/2013

Series C

$99M

10

Date

11/7/2018

10/1/2015

2/19/2015

2/21/2014

2/14/2013

Round

Debt

Series E

Series D - II

Series D

Series C

Amount

$0.48M

$99M

$99M

$99M

$99M

Investors

Undisclosed Investors

Valuation

Revenue

Sources

1

10

10

10

10

Elcelyx Therapeutics Deal Terms

6 Deal Terms

Elcelyx Therapeutics's deal structure is available for 6 funding rounds, including their Series E from October 01, 2015.

Round

Series E

Series D - II

Series C

Series B - II

Series B

Funding Date

$99M

$99M

$99M

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

$99M

$99M

$99M

Dividend Rate

$99M

$99M

$99M

$99M

$99M

Liquidation Preferences

$99M

$99M

$99M

$99M

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

$99M

$99M

$99M

$99M

General Voting

$99M

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series E

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series D - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series C

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series B - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Elcelyx Therapeutics Investors

6 Investors

Elcelyx Therapeutics has 6 investors. Kleiner Perkins Caufield & Byers invested in Elcelyx Therapeutics's Series E funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

5/16/2011

10/1/2015

6
Series B, Series B - II (2012), Series C (2013), Series D (2014), Series D - II (2015), Series E (2015)

Venture Capital

California

00/00/0000

00/00/0000

GSM Fund

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Morgenthaler Ventures

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Clough Global

Subscribe to see more

Asset/Investment Management

Colorado

00/00/0000

00/00/0000

Sailing Capital

Subscribe to see more

Subscribe to see more

Private Equity

China

First funding

5/16/2011

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

10/1/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

GSM Fund

Morgenthaler Ventures

Clough Global

Sailing Capital

Rounds

6
Series B, Series B - II (2012), Series C (2013), Series D (2014), Series D - II (2015), Series E (2015)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Venture Capital

Venture Capital

Venture Capital

Asset/Investment Management

Private Equity

Location

California

California

California

Colorado

China

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.